Why Is Biophytis Stock Up 43 percent Today?
BPTSDelisted Stock | USD 7.03 0.00 0.00% |
Slightly above 56% of Biophytis' investor base is looking to short. The analysis of current outlook of investing in Biophytis suggests that many traders are alarmed regarding Biophytis' prospects. Biophytis' investing sentiment can be driven by a variety of factors including economic data, Biophytis' earnings reports, geopolitical events, and overall market trends.
Biophytis |
Biophytis stock is up on Tuesday after the company provided BPTS shareholders with results for the fiscal full year of 2023
Read at investorplace.com
Biophytis Fundamental Analysis
We analyze Biophytis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biophytis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biophytis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Biophytis is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Biophytis Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biophytis stock to make a market-neutral strategy. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics with similar companies.
Peers
Biophytis Related Equities
NRXPW | NRx Pharmaceuticals | 30.43 | ||||
SPRO | Spero Therapeutics | 9.64 | ||||
TPST | Tempest Therapeutics | 3.33 | ||||
HCWB | HCW Biologics | 2.78 | ||||
RZLT | Rezolute | 2.31 | ||||
IPHA | Innate Pharma | 1.20 | ||||
ARMP | Armata Pharmaceuticals | 0.98 | ||||
INBX | Inhibrx | 0.37 | ||||
XOMAO | XOMA | 0.39 | ||||
AKTX | Akari Therapeutics | 0.83 | ||||
ANEB | Anebulo Pharmaceuticals | 1.85 | ||||
BOLT | Bolt Biotherapeutics | 1.92 | ||||
CHRS | Coherus BioSciences | 2.11 | ||||
PTIX | Protagenic Therapeutics | 2.22 | ||||
NRXP | NRX Pharmaceuticals | 5.87 | ||||
PCSA | Processa Pharmaceuticals | 6.90 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Biophytis Stock
If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |